Advertisement
Screener

SPARK THERAPEUTICS, INC. Operating Income

SPARK THERAPEUTICS, INC. Operating Income

SPARK THERAPEUTICS, INC. reported Operating Income of -$68.66 million for the 3-month period ending 2019-09-30, per its 10-Q filed 2019-11-07.

Discontinued › Income Statement

us-gaap:OperatingIncomeLoss · last filed 2019-11-07

  • SPARK THERAPEUTICS, INC. operating income (loss) for the quarter ending 2019-09-30 was -$68.66M.
  • SPARK THERAPEUTICS, INC. operating income (loss) for the quarter ending 2019-06-30 was -$66.44M.
  • SPARK THERAPEUTICS, INC. operating income (loss) for the quarter ending 2019-03-31 was -$56.85M.
  • SPARK THERAPEUTICS, INC. operating income (loss) for the quarter ending 2018-12-31 was -$58.38M.
  • SPARK THERAPEUTICS, INC. operating income (loss) for fiscal 2018 was -$193.64M.
  • SPARK THERAPEUTICS, INC. operating income (loss) for fiscal 2017 was -$258.52M.
  • SPARK THERAPEUTICS, INC. operating income (loss) for fiscal 2016 was -$125.40M.
  • SPARK THERAPEUTICS, INC. operating income (loss) for fiscal 2015 was -$47.32M.
Period endOperating Income (Loss) 3 monthOperating Income (Loss) 3 month as first filedOperating Income (Loss) 6 monthOperating Income (Loss) 6 month as first filedOperating Income (Loss) 9 monthOperating Income (Loss) 9 month as first filedOperating Income (Loss) 10 monthOperating Income (Loss) 12 monthOperating Income (Loss) 12 month as first filed
2019-09-30-$68.66M
10-Q · filed 2019-11-07
-$135.10M
derived: sum of 2 quarters · filed 2019-11-07
-$191.95M
10-Q · filed 2019-11-07
-$250.33M
derived: sum of 4 quarters · filed 2019-11-07
2019-06-30-$66.44M
10-Q · filed 2019-08-08
-$123.29M
10-Q · filed 2019-08-08
-$181.67M
derived: sum of 3 quarters · filed 2019-08-08
-$233.42M
derived: sum of 4 quarters · filed 2019-11-07
2019-03-31-$56.85M
10-Q · filed 2019-05-10
-$115.23M
derived: sum of 2 quarters · filed 2019-05-10
-$166.97M
derived: sum of 3 quarters · filed 2019-11-07
-$201.57M
derived: sum of 4 quarters · filed 2019-11-07
2018-12-31-$58.38M
10-K · filed 2019-02-28
-$110.13M
derived: sum of 2 quarters · filed 2019-11-07
-$144.73M
derived: sum of 3 quarters · filed 2019-11-07
-$193.64M
10-K · filed 2019-02-28
2018-09-30-$51.74M
10-Q · filed 2019-11-07
-$86.34M
derived: sum of 2 quarters · filed 2019-11-07
-$135.26M
10-Q · filed 2019-11-07
-$198.07M
derived: sum of 4 quarters · filed 2019-11-07
2018-06-30-$34.60M
10-Q · filed 2019-08-08
-$83.51M
10-Q · filed 2019-08-08
-$146.32M
derived: sum of 3 quarters · filed 2019-08-08
-$212.15M
derived: sum of 4 quarters · filed 2019-08-08
2018-03-31-$48.91M
10-Q · filed 2019-05-10
-$111.72M
derived: sum of 2 quarters · filed 2019-05-10
-$177.55M
derived: sum of 3 quarters · filed 2019-05-10
-$254.56M
derived: sum of 4 quarters · filed 2019-05-10
2017-12-31-$62.81M
10-K · filed 2019-02-28
-$62.81M
10-K · filed 2018-02-27
-$128.64M
derived: sum of 2 quarters · filed 2019-02-28
-$205.64M
derived: sum of 3 quarters · filed 2019-02-28
-$258.52M
10-K · filed 2019-02-28
-$258.52M
10-K · filed 2018-02-27
2017-09-30-$65.83M
10-K · filed 2019-02-28
-$65.83M
10-Q · filed 2017-11-07
-$142.83M
derived: sum of 2 quarters · filed 2019-02-28
-$195.71M
10-Q · filed 2018-11-06
-$195.71M
10-Q · filed 2017-11-07
-$233.13M
derived: sum of 4 quarters · filed 2019-02-28
2017-06-30-$77.00M
10-K · filed 2019-02-28
-$77.00M
10-Q · filed 2017-08-02
-$129.88M
10-Q · filed 2018-08-08
-$129.88M
10-Q · filed 2017-08-02
-$167.30M
derived: sum of 3 quarters · filed 2019-02-28
-$200.43M
derived: sum of 4 quarters · filed 2019-02-28
2017-03-31-$52.88M
10-K · filed 2019-02-28
-$52.87M
10-Q · filed 2017-05-10
-$90.30M
derived: sum of 2 quarters · filed 2019-02-28
-$123.43M
derived: sum of 3 quarters · filed 2019-02-28
-$152.44M
derived: sum of 4 quarters · filed 2019-02-28
2016-12-31-$37.42M
10-K · filed 2018-02-27
-$70.55M
derived: sum of 2 quarters · filed 2018-02-27
-$99.56M
derived: sum of 3 quarters · filed 2018-02-27
-$125.40M
10-K · filed 2019-02-28
-$125.40M
10-K · filed 2017-02-28
2016-09-30-$33.13M
10-K · filed 2018-02-27
-$62.14M
derived: sum of 2 quarters · filed 2018-02-27
-$87.98M
10-Q · filed 2017-11-07
-$94.21M
derived: sum of 4 quarters · filed 2018-02-27
2016-06-30-$29.01M
10-K · filed 2018-02-27
-$54.85M
10-Q · filed 2017-08-02
-$61.08M
derived: sum of 3 quarters · filed 2018-02-27
-$78.03M
derived: sum of 4 quarters · filed 2018-02-27
2016-03-31-$25.84M
10-K · filed 2018-02-27
-$32.07M
derived: sum of 2 quarters · filed 2018-02-27
-$49.02M
derived: sum of 3 quarters · filed 2018-02-27
-$63.41M
derived: sum of 4 quarters · filed 2018-02-27
2015-12-31-$6.23M
10-K · filed 2017-02-28
-$23.18M
derived: sum of 2 quarters · filed 2017-02-28
-$37.57M
derived: sum of 3 quarters · filed 2017-02-28
-$47.32M
10-K · filed 2018-02-27
2015-09-30-$16.96M
10-K · filed 2017-02-28
-$31.34M
derived: sum of 2 quarters · filed 2017-02-28
-$41.09M
10-Q · filed 2016-11-04
-$50.11M
derived: sum of 4 quarters · filed 2017-02-28
2015-06-30-$14.39M
10-K · filed 2017-02-28
-$24.13M
10-Q · filed 2016-08-10
-$33.15M
derived: sum of 3 quarters · filed 2017-02-28
-$39.91M
derived: sum of 4 quarters · filed 2017-02-28
2015-03-31-$9.74M
10-K · filed 2017-02-28
-$18.76M
derived: sum of 2 quarters · filed 2017-02-28
-$25.52M
derived: sum of 3 quarters · filed 2017-02-28
-$29.69M
derived: sum of 4 quarters · filed 2017-02-28
2014-12-31-$9.02M
10-K · filed 2016-03-14
-$15.78M
derived: sum of 2 quarters · filed 2016-03-14
-$19.95M
derived: sum of 3 quarters · filed 2016-03-14
-$24.33M
10-K · filed 2017-02-28
2014-09-30-$6.76M
10-K · filed 2016-03-14
-$10.93M
derived: sum of 2 quarters · filed 2016-03-14
-$15.31M
10-Q · filed 2015-11-06
2014-06-30-$4.17M
10-K · filed 2016-03-14
-$8.55M
10-Q · filed 2015-08-07
2014-03-31-$4.38M
10-K · filed 2016-03-14
2013-12-31-$57.28M
10-K · filed 2016-03-14